NAMPT and endothelial dysfunction: In addition to the potential indirect role of visfatin in cardiovascular disease through metabolic syndrome and inflammation, visfatin has been demonstrated to induce endothelial dysfunction in vivo, which has a pivotal role in initiation and progress of atherosclerosis [47].